Eton Pharmaceuticals(ETON)
$61.99-1.66 (-2.61%)
ETON
Eton Pharmaceuticals financials statements
$61.99
At close:-1.66 (-2.61%)
Want to see ETON full AI Analyst Report?
Eton Pharmaceuticals (ETON) Ratios
603 Followers
Eton Pharmaceuticals Ratios
ETON's free cash flow for Q3 2026 was $35.23M. For the 2026 fiscal year, ETON's free cash flow was decreased by $-13.00K and operating cash flow was $35.24M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.57 | 2.06 | 1.65 | 3.10 | 5.18 |
| Quick Ratio | 1.17 | 1.29 | 1.60 | 3.01 | 5.06 |
| Cash Ratio | 0.67 | 0.75 | 1.32 | 2.52 | 3.16 |
| Solvency Ratio | -0.01 | -0.05 | -0.00 | -0.61 | -0.15 |
| Operating Cash Flow Ratio | 0.27 | 0.05 | 0.42 | 0.75 | -1.04 |
| Short-Term Operating Cash Flow Coverage | 1.20 | 12.75 | 1.27 | 4.67 | -3.33 |
| Net Current Asset Value | $ -5.38M | $ -10.67M | $ 10.58M | $ 8.05M | $ 13.77M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.34 | 0.39 | 0.17 | 0.26 | 0.24 |
| Debt-to-Equity Ratio | 1.19 | 1.23 | 0.35 | 0.50 | 0.38 |
| Debt-to-Capital Ratio | 0.54 | 0.55 | 0.26 | 0.33 | 0.28 |
| Long-Term Debt-to-Capital Ratio | 0.45 | 0.55 | 0.00 | 0.29 | 0.23 |
| Financial Leverage Ratio | 3.52 | 3.12 | 2.05 | 1.91 | 1.56 |
| Debt Service Coverage Ratio | 0.31 | -0.32 | -0.10 | -6.28 | -0.73 |
| Interest Coverage Ratio | 0.02 | -1.30 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.07 | 0.09 | 0.05 | 0.09 | 0.06 |
| Interest Debt Per Share | 1.33 | 1.24 | 0.21 | 0.26 | 0.27 |
| Net Debt to EBITDA | 1.19 | -22.92 | 54.93 | 1.51 | 7.46 |
| Profitability Margins | |||||
| Gross Profit Margin | 53.46% | 60.01% | 66.56% | 67.38% | 87.99% |
| EBIT Margin | 0.28% | -4.62% | -3.77% | -38.87% | -6.85% |
| EBITDA Margin | 5.34% | -1.68% | -0.92% | -30.52% | -4.73% |
| Operating Profit Margin | 0.09% | -6.66% | -3.77% | -38.87% | -6.85% |
| Pretax Profit Margin | -5.70% | -9.76% | -2.18% | -42.45% | -8.95% |
| Net Profit Margin | -5.75% | -9.80% | -2.96% | -42.45% | -8.95% |
| Continuous Operations Profit Margin | -5.75% | -9.80% | -2.96% | -42.45% | -8.95% |
| Net Income Per EBT | 100.94% | 100.39% | 135.85% | 100.00% | 100.00% |
| EBT Per EBIT | -6330.56% | 146.63% | 57.80% | 109.21% | 130.77% |
| Return on Assets (ROA) | -4.99% | -5.02% | -2.95% | -36.04% | -7.12% |
| Return on Equity (ROE) | -17.59% | -15.65% | -6.05% | -68.98% | -11.09% |
| Return on Capital Employed (ROCE) | 0.13% | -4.62% | -7.69% | -44.48% | -6.53% |
| Return on Invested Capital (ROIC) | 0.12% | -4.62% | -5.71% | -42.14% | -6.15% |
| Return on Tangible Assets | -7.51% | -9.27% | -3.47% | -44.49% | -8.20% |
| Earnings Yield | -1.01% | -1.11% | -0.83% | -12.72% | -1.81% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.80 | 7.28 | 9.28 | 11.47 | 3.99 |
| Payables Turnover | 3.39 | 3.74 | 5.73 | 3.93 | 1.48 |
| Inventory Turnover | 2.41 | 1.02 | 11.61 | 12.45 | 4.77 |
| Fixed Asset Turnover | 125.71 | 186.66 | 210.95 | 81.73 | 99.69 |
| Asset Turnover | 0.87 | 0.51 | 1.00 | 0.85 | 0.79 |
| Working Capital Turnover Ratio | 3.70 | 2.46 | 2.62 | 1.30 | 1.09 |
| Cash Conversion Cycle | 97.26 | 309.05 | 7.02 | -31.84 | -78.86 |
| Days of Sales Outstanding | 53.67 | 50.16 | 39.35 | 31.81 | 91.47 |
| Days of Inventory Outstanding | 151.25 | 356.39 | 31.43 | 29.32 | 76.53 |
| Days of Payables Outstanding | 107.67 | 97.50 | 63.75 | 92.97 | 246.86 |
| Operating Cycle | 204.92 | 406.55 | 70.77 | 61.13 | 168.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.39 | 0.04 | 0.27 | 0.19 | -0.19 |
| Free Cash Flow Per Share | 0.38 | 0.04 | 0.24 | 0.08 | -0.32 |
| Dividend Paid and CapEx Coverage Ratio | 31.60 | 37.27 | 8.79 | 1.73 | -1.45 |
| Capital Expenditure Coverage Ratio | 31.60 | 37.27 | 8.79 | 1.73 | -1.45 |
| Operating Cash Flow Coverage Ratio | 0.34 | 0.03 | 1.26 | 0.74 | -0.71 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.02 | 0.22 | 0.23 | -0.22 |
| Free Cash Flow Yield | 2.24% | 0.27% | 5.38% | 2.87% | -7.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -99.47 | -88.80 | -120.01 | -7.86 | -55.31 |
| Price-to-Sales (P/S) Ratio | 5.69 | 8.84 | 3.55 | 3.34 | 4.95 |
| Price-to-Book (P/B) Ratio | 17.40 | 14.12 | 7.26 | 5.42 | 6.13 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 44.65 | 365.77 | 18.60 | 34.88 | -13.55 |
| Price-to-Operating Cash Flow Ratio | 43.24 | 355.96 | 16.48 | 14.71 | -22.91 |
| Price-to-Earnings Growth (PEG) Ratio | -7.46 | -0.29 | 1.34 | -0.02 | 0.59 |
| Enterprise Value Multiple | 107.83 | -547.91 | -331.06 | -9.42 | -97.22 |
| Enterprise Value | 460.09M | 359.98M | 96.34M | 61.13M | 100.43M |
| EV to EBITDA | 107.83 | -547.91 | -331.06 | -9.42 | -97.22 |
| EV to Sales | 5.75 | 9.23 | 3.04 | 2.88 | 4.60 |
| EV to Free Cash Flow | 45.15 | 381.74 | 15.95 | 30.07 | -12.58 |
| EV to Operating Cash Flow | 43.72 | 371.50 | 14.14 | 12.68 | -21.27 |
| Tangible Book Value Per Share | -0.18 | -0.40 | 0.42 | 0.33 | 0.56 |
| Shareholders’ Equity Per Share | 0.97 | 0.94 | 0.60 | 0.52 | 0.70 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | -0.36 | 0.00 | 0.00 |
| Revenue Per Share | 2.97 | 1.51 | 1.23 | 0.85 | 0.87 |
| Net Income Per Share | -0.17 | -0.15 | -0.04 | -0.36 | -0.08 |
| Tax Burden | 1.01 | 1.00 | 1.36 | 1.00 | 1.00 |
| Interest Burden | -20.44 | 2.11 | 0.58 | 1.09 | 1.31 |
| Research & Development to Revenue | 0.10 | 0.08 | 0.10 | 0.19 | 0.29 |
| SG&A to Revenue | 0.45 | 0.58 | 0.60 | 0.87 | 0.66 |
| Stock-Based Compensation to Revenue | 0.07 | 0.08 | 0.10 | 0.20 | 0.15 |
| Income Quality | -2.29 | -0.25 | -7.28 | -0.53 | 2.41 |
Currency in USD

